Bioregenx (BRGX) Operating Income (2022 - 2026)
Bioregenx (BRGX) recorded quarterly Operating Income of -$49764.0 in Q1 2026, up 94.68% quarter-over-quarter from -$935658.0 in Q4 2025, and up 74.16% on a YoY basis from -$28573.1 in Q1 2025.
Bioregenx (BRGX) Operating Income (2022 - 2026) Analysis & Trends
Bioregenx's Operating Income history runs 5 years deep, the most recent figure standing at -$49764.0 for Q1 2026.
- In Q1 2026, Operating Income rose 74.16% year-over-year to -$49764.0; the TTM figure through Mar 2026 stood at -$1.1 million (up 94.46% YoY), while the FY2025 annual figure was -$1.2 million, up 94.54% from the prior year.
- Operating Income was -$49764.0 for Q1 2026 at Bioregenx, up from -$935658.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$2191.0 in Q3 2022 to a low of -$18.3 million in Q4 2024.
- Historically, Operating Income has averaged -$1.6 million across 5 years, with a median of -$192615.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Operating Income slumped 112567.87% in 2023, then surged 97.42% in 2025.
- A 5-year view of Operating Income shows it stood at -$5535.0 in 2022, then sank by 3722.13% to -$211555.0 in 2023, then slumped by 8558.18% to -$18.3 million in 2024, then surged by 94.89% to -$935658.0 in 2025, then surged by 94.68% to -$49764.0 in 2026.
- The last three Operating Income figures came in at -$49764.0 (Q1 2026), -$935658.0 (Q4 2025), and -$8459.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 273.11 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 121.45 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 102.95 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 32.07 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -17.05 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 24.83 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 80.47 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 7.42 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 16.85 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | -49,764.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49,764.00 |
| Dec 31, 2025 | -935,658.00 |
| Sep 30, 2025 | -8,459.00 |
| Jun 30, 2025 | -107,259.00 |
| Mar 31, 2025 | -192,615.00 |
| Dec 31, 2024 | -18.32 Mn |
| Sep 30, 2024 | -327,307.00 |
| Jun 30, 2024 | -1.04 Mn |
| Mar 31, 2024 | -3.08 Mn |
| Dec 31, 2023 | -211,555.00 |
| Sep 30, 2023 | -2.47 Mn |
| Jun 30, 2023 | -544,619.00 |
| Mar 31, 2023 | -184,106.00 |
| Dec 31, 2022 | -5,535.00 |
| Sep 30, 2022 | -2,191.00 |
| Jun 30, 2022 | -33,263.00 |
| Mar 31, 2022 | -37,319.00 |